Global Immunodiagnostics Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Immunodiagnostics Industry By The Forecast Year 2029?

The sphere of immunodiagnostics has experienced robust expansion lately, projected to increase its valuation from $22.88 billion in 2024 to $24.32 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.3%. This upward trajectory over the recent past is fueled by several factors, including the escalating frequency of infectious disease outbreaks, a greater prevalence of autoimmune conditions, advancements in cancer detection and ongoing management, the worldwide spread of communicable illnesses, and expanded governmental health campaigns alongside systematic screening efforts.

The sector for immunodiagnostics is projected to experience a robust expansion over the coming years, reaching a valuation of $32.89 billion by 2029, driven by a compound annual growth rate (CAGR) of 7.8%; this upswing is fueled by factors such as readiness for and responses to pandemics, advancements in individualized medical treatments and the identification of biomarkers, the enhancement of medical facilities in developing economies, better incorporation with laboratory management software, and the increasing prevalence of long-term illnesses. Key developments shaping this market include the adoption of multiplexing techniques, the growth of testing at the point of care (POCT), continued focus on discovering biomarkers and tailoring treatments to individuals, the increasing digitalization of immunodiagnostic processes, and a move towards utilizing liquid biopsies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

What Are The Main Drivers Boosting The Immunodiagnostics Industry’s Expansion?

The expanding occurrence of transmissible ailments is anticipated to fuel the advancement of the immunodiagnostics sector in the near term. Such illnesses, caused by pathogens like viruses, bacteria, fungi, or parasites, spread among individuals. To pinpoint a virus within a blood specimen, an immunodiagnostic test is employed. As an illustration, the US government body, the Centers for Disease Control and Prevention, reported in March 2024 that tuberculosis instances climbed by 1,295, moving from 8,320 in 2022 up to 9,615 in 2023; consequently, this rising incidence of infectious diseases is projected to provide a lift to the market for immunodiagnostics.

How Is The Immunodiagnostics Market Segmented?

The immunodiagnosticsmarket covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments, Software And Services

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Which Market Trends Are Creating New Opportunities In The Immunodiagnostics Industry?

Leading firms within the immunodiagnostics sector are concentrating their efforts on creating novel diagnostic tools, specifically focusing on tests like the S. pneumoniae antigen immunodiagnostic assay, intended to improve the identification of pneumococcal pneumonia. This particular assay functions by identifying Streptococcus pneumoniae antigens within biological specimens, thereby assisting clinicians in confirming pneumococcal infection diagnoses. As an illustration, in September of the year 2024, the Italian biotechnology firm DiaSorin S.p.A. introduced its LIAISON S. pneumoniae antigen immunodiagnostic assay. Designed for qualitative identification of Streptococcus pneumoniae antigens present in urine specimens collected from adult patients exhibiting symptoms of presumed pneumococcal pneumonia, the LIAISON S. pneumoniae Antigen Immunodiagnostic Assay delivers a high-volume testing capability, empowering medical professionals to rapidly diagnose and differentiate pneumococcal pneumonia from other concurrent respiratory illnesses. Executed on LIAISON CLIA platforms, the test yields actionable results within a swift 35-minute timeframe, enabling timely and precisely aimed antimicrobial treatment. Furthermore, the capacity of this assay to recognize ninety-one distinct serotypes significantly sharpens clinical judgment and bolsters judicious antibiotic usage, representing a notable advancement in immunodiagnostics for community-acquired pneumonia cases.

Which Global Market Leaders Are Shaping The Future Of The Immunodiagnostics Sector?

Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Immunodiagnostics Market?

North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Immunodiagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

Browse Through More Reports Similar to the Global Immunodiagnostics Market 2025, By The Business Research Company

Orphan Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795